CIBC World Keeps Sector Outperform on QLT
QLT Inc. (QLTI ) received FDA approval for a 6-month formulation of its Eligard compound. CIBC World reiterated its sector outperform rating on the shares.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.